KALARIS
Live / Allowed — Notice of allowance issued (as of 07 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Oct 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98831274
- Mark type
- Stylized text
- Filed
- 31 Oct 2024
- Published for opposition
- 03 Jun 2025
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of retinal and ophthalmological conditions, diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development for the treatment of retinal and ophthalmological conditions, diseases, and disorders
Owner
- Kalaris Therapeutics, Inc., Palo Alto, CA, US
- Kalaris Therapeutics, Inc., Palo Alto, CA, US
Prosecution history
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 May 2025 — ASSIGNED TO EXAMINER
- 25 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 Oct 2024 — NEW APPLICATION ENTERED